Novartis marketing breach sparks PMCPA call for companies to be ‘on high alert’
Failures at Novartis have prompted the U.K. marketing watchdog to warn that “companies should be on high alert” when working with third parties to promote materials about medical conferences.
Failures at Novartis have prompted the U.K. marketing watchdog to warn that “companies should be on high alert” when working with third parties to promote materials about medical conferences.
